<p>加利福尼亚公共雇员退休系统在最近向美国证券交易委员会提交的 13F 表格中表示，在第二季度将其在 Kenvue Inc.（纽约证券交易所代码：KVUE - 免费报告）的持股增加了 4.0%。该机构投资者在此期间额外购买了 123,636 股后，持有该公司 3,242,423 股股票。截至其最近的 SEC 文件，加利福尼亚公共雇员退休系统持有 Kenvue 0.17% 的股份，价值 67,864,000 美元。</p>
<ul>
<li>3 只适合不安市场的防御性股票</li>
</ul>
<p>其他对冲基金和机构投资者最近也对该公司的持股进行了调整。Atria Wealth Solutions Inc.在第一季度将其在 Kenvue 的持股增加了 48.0%。Atria Wealth Solutions Inc.现在持有 27,022 股该公司的股票，价值 648,000 美元，此前在上个季度额外购买了 8,765 股。AlphaCore Capital LLC 在第一季度购买了 Kenvue 的新股份，价值约 115,000 美元。Townsquare Capital LLC 在第一季度将其在 Kenvue 的持股增加了 8.6%。Townsquare Capital LLC 现在持有 31,273 股该公司的股票，价值 750,000 美元，此前在上个季度额外购买了 2,477 股。Connor Clark &amp; Lunn Investment Management Ltd.在第一季度将其在 Kenvue 的持股增加了 39.2%。Connor Clark &amp; Lunn Investment Management Ltd.现在持有 29,030 股该公司的股票，价值 696,000 美元，此前在上个季度额外购买了 8,178 股。最后，Frank Rimerman Advisors LLC 在第一季度购买了 Kenvue 的新股份，价值约 444,000 美元。97.64% 的股票由机构投资者持有。</p>
<h2>分析师设定新目标价</h2>
<p>KVUE 成为多份研究报告的主题。Redburn Partners 在 9 月 26 日的研究报告中将 Kenvue 的目标价设定为 22.00 美元。巴克莱在 11 月 10 日的报告中将 Kenvue 的目标价从 17.00 美元上调至 18.00 美元，并给予该股票 “持平” 评级。Johnson Rice 在 10 月 28 日的报告中重申了对 Kenvue 的 “中性” 评级。Weiss Ratings 在 10 月 14 日的研究报告中重申了对 Kenvue 的 “持有（c-）” 评级。最后，Canaccord Genuity Group 在 10 月 29 日的研究报告中重申了 “持有” 评级，并将 Kenvue 的目标价设定为 15.00 美元（从 26.00 美元下调）。一位研究分析师对该股票给予了强烈买入评级，五位分析师给予买入评级，十三位分析师给予持有评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 20.23 美元。</p>
<ul>
<li>贴纸震惊：金佰利的抛售为何是过度反应</li>
</ul>
<p><strong>查看我们最新的 Kenvue 股票分析</strong></p>
<h2>Kenvue 股票表现</h2>
<p>Kenvue（纽约证券交易所代码：KVUE）周二开盘价为 16.78 美元。该公司的流动比率为 0.98，速动比率为 0.69，债务与股本比率为 0.66。Kenvue Inc.的 12 个月低点为 14.02 美元，12 个月高点为 25.17 美元。该公司的市值为 321.5 亿美元，市盈率为 22.38，贝塔值为 0.59。该公司的 50 日移动平均线为 16.10 美元，200 日移动平均线为 19.24 美元。</p>
<ul>
<li>持有评级，高回报？3 只可能超出预期的股票</li>
</ul>
<p>Kenvue（纽约证券交易所代码：KVUE - 获取免费报告）最后一次公布财报是在 11 月 3 日。该公司报告季度每股收益（EPS）为 0.28 美元，超出市场共识预期的 0.27 美元 0.01 美元。该季度的营业收入为 37.6 亿美元，而分析师预期为 38.3 亿美元。Kenvue 的股本回报率为 20.02%，净利润率为 9.55%。与去年同期相比，该公司的季度收入下降了 3.5%。在去年同期，该公司每股收益为 0.28 美元。Kenvue 已将其 2025 财年的指引设定为 1.000-1.050 EPS。研究分析师预测 Kenvue Inc.今年将发布 1.14 EPS。</p>
<h2>Kenvue 股息公告</h2>
<p>该公司最近还披露了季度股息，已于 11 月 26 日支付。11 月 12 日的股东获得了 0.2075 美元的股息。这代表着每年 0.83 美元的股息，收益率为 4.9%。该股息的除息日期为 11 月 12 日。Kenvue 的股息支付比率为 110.67%。</p>
<h2>Kenvue 简介</h2>
<p>（免费报告）</p>
<p>Kenvue Inc.是一家全球消费健康公司。该公司通过三个部门运营：自我护理、皮肤健康与美容以及基本健康。自我护理部门提供咳嗽、感冒和过敏、疼痛护理、消化健康、戒烟、眼部护理及其他产品，品牌包括泰诺、莫特林、苯海拉明、尼古丁替代品、Zarbee's、ORSLTM、Rhinocort、Calpol 和 Zyrtec。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票比 Kenvue 更好</li>
<li>基础材料股票投资</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
<li>3 只可以提升您投资组合的家居改善股票</li>
<li>3 只最有可能在 2026 年拆分的股票</li>
<li>为什么这些公司被认为是蓝筹股？</li>
<li>ChargePoint 的复苏故事：为什么这只电动车股票再次充电</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUtWVUU?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUtWVUU"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Kenvue 吗？</h2>
<p>在考虑 Kenvue 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Kenvue 并不在名单上。</p>
<p>虽然 Kenvue 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

KVUE

<p>加利福尼亚公共雇员退休系统在第二季度将其在 Kenvue Inc.的持股增加了 4%，目前持有 3,242,423 股，价值 6,786 万美元。Kenvue 的股票获得了一致的 “持有” 评级，目标价格为 20.23 美元。该公司报告第三季度每股收益为 0.28 美元，略高于预期，收入同比下降 3.5%。Kenvue 宣布每股季度股息为 0.2075 美元，年收益率为 4.9%</p>

<p>California Public Employees Retirement System boosted its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,242,423 shares of the company's stock after acquiring an additional 123,636 shares during the period. California Public Employees Retirement System owned 0.17% of Kenvue worth $67,864,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>加利福尼亚公共雇员退休系统在最近向美国证券交易委员会提交的 13F 表格中表示，在第二季度将其在 Kenvue Inc.（纽约证券交易所代码：KVUE - 免费报告）的持股增加了 4.0%。该机构投资者在此期间额外购买了 123,636 股后，持有该公司 3,242,423 股股票。截至其最近的 SEC 文件，加利福尼亚公共雇员退休系统持有 Kenvue 0.17% 的股份，价值 67,864,000 美元。</p>
</div><ul>
<li>3 Smart Defensive Stocks for an Uneasy Market</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只适合不安市场的防御性股票</li>
</ul>
</div><p>Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atria Wealth Solutions Inc. lifted its position in shares of Kenvue by 48.0% during the 1st quarter. Atria Wealth Solutions Inc. now owns 27,022 shares of the company's stock worth $648,000 after buying an additional 8,765 shares in the last quarter. AlphaCore Capital LLC bought a new position in shares of Kenvue in the first quarter worth approximately $115,000. Townsquare Capital LLC raised its position in Kenvue by 8.6% during the first quarter. Townsquare Capital LLC now owns 31,273 shares of the company's stock valued at $750,000 after purchasing an additional 2,477 shares in the last quarter. Connor Clark &amp; Lunn Investment Management Ltd. lifted its holdings in shares of Kenvue by 39.2% in the 1st quarter. Connor Clark &amp; Lunn Investment Management Ltd. now owns 29,030 shares of the company's stock worth $696,000 after acquiring an additional 8,178 shares during the last quarter. Finally, Frank Rimerman Advisors LLC purchased a new stake in Kenvue during the 1st quarter valued at about $444,000. 97.64% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金和机构投资者最近也对该公司的持股进行了调整。Atria Wealth Solutions Inc.在第一季度将其在 Kenvue 的持股增加了 48.0%。Atria Wealth Solutions Inc.现在持有 27,022 股该公司的股票，价值 648,000 美元，此前在上个季度额外购买了 8,765 股。AlphaCore Capital LLC 在第一季度购买了 Kenvue 的新股份，价值约 115,000 美元。Townsquare Capital LLC 在第一季度将其在 Kenvue 的持股增加了 8.6%。Townsquare Capital LLC 现在持有 31,273 股该公司的股票，价值 750,000 美元，此前在上个季度额外购买了 2,477 股。Connor Clark &amp; Lunn Investment Management Ltd.在第一季度将其在 Kenvue 的持股增加了 39.2%。Connor Clark &amp; Lunn Investment Management Ltd.现在持有 29,030 股该公司的股票，价值 696,000 美元，此前在上个季度额外购买了 8,178 股。最后，Frank Rimerman Advisors LLC 在第一季度购买了 Kenvue 的新股份，价值约 444,000 美元。97.64% 的股票由机构投资者持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>KVUE has been the subject of a number of research reports. Redburn Partners set a $22.00 price target on shares of Kenvue in a research note on Friday, September 26th. Barclays lifted their target price on Kenvue from $17.00 to $18.00 and gave the stock an &#34;equal weight&#34; rating in a report on Monday, November 10th. Johnson Rice reissued a &#34;neutral&#34; rating on shares of Kenvue in a report on Tuesday, October 28th. Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of Kenvue in a research note on Tuesday, October 14th. Finally, Canaccord Genuity Group reiterated a &#34;hold&#34; rating and set a $15.00 target price (down from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of &#34;Hold&#34; and a consensus price target of $20.23.</p>
<div class="lb-trans"><p>KVUE 成为多份研究报告的主题。Redburn Partners 在 9 月 26 日的研究报告中将 Kenvue 的目标价设定为 22.00 美元。巴克莱在 11 月 10 日的报告中将 Kenvue 的目标价从 17.00 美元上调至 18.00 美元，并给予该股票 “持平” 评级。Johnson Rice 在 10 月 28 日的报告中重申了对 Kenvue 的 “中性” 评级。Weiss Ratings 在 10 月 14 日的研究报告中重申了对 Kenvue 的 “持有（c-）” 评级。最后，Canaccord Genuity Group 在 10 月 29 日的研究报告中重申了 “持有” 评级，并将 Kenvue 的目标价设定为 15.00 美元（从 26.00 美元下调）。一位研究分析师对该股票给予了强烈买入评级，五位分析师给予买入评级，十三位分析师给予持有评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 20.23 美元。</p>
</div><ul>
<li>Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction</li>
</ul>
<div class="lb-trans"><ul>
<li>贴纸震惊：金佰利的抛售为何是过度反应</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on Kenvue</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Kenvue 股票分析</strong></p>
</div><h2>Kenvue Stock Performance</h2>
<div class="lb-trans"><h2>Kenvue 股票表现</h2>
</div><p>Shares of NYSE:KVUE opened at $16.78 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company has a market capitalization of $32.15 billion, a price-to-earnings ratio of 22.38 and a beta of 0.59. The firm's 50-day moving average is $16.10 and its 200 day moving average is $19.24.</p>
<div class="lb-trans"><p>Kenvue（纽约证券交易所代码：KVUE）周二开盘价为 16.78 美元。该公司的流动比率为 0.98，速动比率为 0.69，债务与股本比率为 0.66。Kenvue Inc.的 12 个月低点为 14.02 美元，12 个月高点为 25.17 美元。该公司的市值为 321.5 亿美元，市盈率为 22.38，贝塔值为 0.59。该公司的 50 日移动平均线为 16.10 美元，200 日移动平均线为 19.24 美元。</p>
</div><ul>
<li>Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations</li>
</ul>
<div class="lb-trans"><ul>
<li>持有评级，高回报？3 只可能超出预期的股票</li>
</ul>
</div><p>Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.</p>
<div class="lb-trans"><p>Kenvue（纽约证券交易所代码：KVUE - 获取免费报告）最后一次公布财报是在 11 月 3 日。该公司报告季度每股收益（EPS）为 0.28 美元，超出市场共识预期的 0.27 美元 0.01 美元。该季度的营业收入为 37.6 亿美元，而分析师预期为 38.3 亿美元。Kenvue 的股本回报率为 20.02%，净利润率为 9.55%。与去年同期相比，该公司的季度收入下降了 3.5%。在去年同期，该公司每股收益为 0.28 美元。Kenvue 已将其 2025 财年的指引设定为 1.000-1.050 EPS。研究分析师预测 Kenvue Inc.今年将发布 1.14 EPS。</p>
</div><h2>Kenvue Dividend Announcement</h2>
<div class="lb-trans"><h2>Kenvue 股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.9%. The ex-dividend date of this dividend was Wednesday, November 12th. Kenvue's dividend payout ratio is 110.67%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，已于 11 月 26 日支付。11 月 12 日的股东获得了 0.2075 美元的股息。这代表着每年 0.83 美元的股息，收益率为 4.9%。该股息的除息日期为 11 月 12 日。Kenvue 的股息支付比率为 110.67%。</p>
</div><h2>Kenvue Profile</h2>
<div class="lb-trans"><h2>Kenvue 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.</p>
<div class="lb-trans"><p>Kenvue Inc.是一家全球消费健康公司。该公司通过三个部门运营：自我护理、皮肤健康与美容以及基本健康。自我护理部门提供咳嗽、感冒和过敏、疼痛护理、消化健康、戒烟、眼部护理及其他产品，品牌包括泰诺、莫特林、苯海拉明、尼古丁替代品、Zarbee's、ORSLTM、Rhinocort、Calpol 和 Zyrtec。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Kenvue</li>
<li>Basic Materials Stocks Investing</li>
<li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li>
<li>3 Home Improvement Stocks that Can Upgrade Your Portfolio</li>
<li>3 Stocks Most Likely to Split in 2026</li>
<li>Why Are These Companies Considered Blue Chips?</li>
<li>ChargePoint's Comeback Story: Why This EV Stock Is Charging Up Again</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Kenvue 更好</li>
<li>基础材料股票投资</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
<li>3 只可以提升您投资组合的家居改善股票</li>
<li>3 只最有可能在 2026 年拆分的股票</li>
<li>为什么这些公司被认为是蓝筹股？</li>
<li>ChargePoint 的复苏故事：为什么这只电动车股票再次充电</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUtWVUU" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=KVUE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Kenvue Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Kenvue 吗？</h2>
</div><p>Before you consider Kenvue, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Kenvue 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Kenvue 并不在名单上。</p>
</div><p>While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Kenvue 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

加州公共雇员退休系统在 Kenvue Inc. $KVUE 中持有 6786 万美元的投资